Panel Discussion: Utilizing Preclinical Findings to Influence and Improve Clinical Trial Design in Complement-Based Drug Development

Time: 9:10 am
day: Conference Day Two


  • Strategies for translating preclinical findings into actionable clinical trial plans, including dose selection, patient population identification, and endpoint determination
  • Biomarkers identified in preclinical studies that can be used for patient stratification, monitoring drug response, and predicting outcomes
  • Adaptive clinical trial designs that allow flexibility from insights from preclinical stages